Cited by 308Pancreatic function and diabetesDiabetes Treatment and ManagementGenetic Associations and Epidemiology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Open access

Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.·2007·Diabetologia

DOI 10.1007/s00125-007-0753-6PMC PMC2063563

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes and reduced insulin secretion. The transcription factor TCF7L2 is an essential factor for glucagon-like peptide-1 (GLP-1) secretion from intestinal L cells. We studied whether a defect in the enteroinsular axis contributes to impaired insulin secretion in carriers of TCF7L2 polymorphisms.Methods We genotyped 1,110 non-diabetic German participants for five single nucleotide polymorphisms in TCF7L2. All participants underwent an OGTT; GLP-1 secretion was measured in 155 participants. In 210 participants, an IVGTT combined with a hyperinsulinaemic-euglycaemic clamp was performed. In another 160 participants from the Netherlands and 73 from Germany, a hyperglycaemic clamp (10 mmol/l) was performed. In 73 German participants this clamp was combined with a GLP-1 infusion and an arginine bolus.Results The OGTT data confirmed that variants in TCF7L2 are associated with reduced insulin secretion. In contrast, insulin secretion induced by an i.v. glucose challenge in the IVGTT and hyperglycaemic clamp was not different between the genotypes. GLP-1 concentrations during the OGTT were not influenced by the TCF7L2 variants. However, GLP-1-infusion combined with a hyperglycaemic clamp showed a significant reduction in GLP-1-induced insulin secretion in carriers of the risk allele in two variants (rs7903146, rs12255372, p < 0.02).Conclusions/interpretation Variants of TCF7L2 specifically impair GLP-1-induced insulin secretion. This seems to be rather the result of a functional defect in the GLP-1 signalling in beta cells than a reduction in GLP-1 secretion. This defect might explain the impaired insulin secretion in carriers of the risk alleles and confers the increased risk of type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-007-0753-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 834
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Self-citation
Glucagon-Like Peptide-1-(7–36)Amide Is Transformed to Glucagon-Like Peptide-1-(9–36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine1
Hansen, L., Deacon, C. F., Ørskov, C., & Holst, J. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7143 · Cited by 595
Self-citation
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
Helgason, A., Pálsson, S., Þorleifsson, G., Grant, S. F. A., Emilsson, V., Gunnarsdottir, S., Adeyemo, A., Chen, Y., Chen, G., Reynisdóttir, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1960 · Cited by 529
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by β-Catenin and Glycogen Synthase Kinase-3β
Yi, F., Brubaker, P. L., & Jin, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411487200 · Cited by 417
WOMEN AND MEN
Scheinfeld, A. (1945) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194507000-00025 · Cited by 381
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals
Saxena, R., Gianniny, L., Burtt, N. P., Lyssenko, V., Giuducci, C., Sjögren, M., Florez, J. C., Almgren, P., Isomaa, B., Orho‐Melander, M., et al. (2006) · Diabetes · doi:10.2337/db06-0381 · Cited by 373
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stümvoll, M., & Häring, H. U. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 329
Self-citation

Show all 30 references

Sorted by citations

Items 201–300 of 308

Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis
Song, Z., Tang, Y., Peng, M., Han, R., & He, P. (2025) · Pharmaceuticals · doi:10.3390/ph18091261 · Cited by 15
Evolving to Personalized Medicine for Type 2 Diabetes
Reddy, S. S. K. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.07.001 · Cited by 12
TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population
Potapov, V. A., Chistiakov, D. A., Шамхалова, М. Ш., Shestakova, M. V., & Nosikov, V. V. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.07.005 · Cited by 11
Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with impaired proinsulin conversion—A meta-analysis
Shen, J., Fang, Y., & Ge, W. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.020 · Cited by 10
Single Nucleotide Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphisms in Antiislet Autoantibody-Negative Patients at Onset of Diabetes
Yu, J., Steck, A. K., Babu, S. R., Yu, L., Miao, D., McFann, K., Hutton, J. C., Eisenbarth, G. S., & KLINGENSMITH, G. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2694 · Cited by 11
Methylation of Tcf712 promoter by high‐fat diet impairs β‐cell function in mouse pancreatic islets
Hu, Y., Shi, P., He, K., Zhu, Y., Yang, F., Yang, M., He, B., & Mao, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2980 · Cited by 10
Pharmacogenetic Aspects of the Treatment of Type 2 Diabetes with the Incretin Effect Enhancers
Tkáč, I., & Gotthardová, I. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0011 · Cited by 11
Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits
Fritsche, L., Sarief, M., Wagner, R. J., Stefan, N., Lehmann, R., Häring, H., Grallert, H., Fritsche, A., & Lechner, A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.11.003 · Cited by 10
Self-citation
CDKAL1 (rs10946398) and TCF7L2 (rs7903146) gene polymorphisms and their association with risk of type-2 diabetes mellitus in population of Uttarakhand, India
Verma, A. K., Beg, M. M. A., Khan, N. A., Goyal, Y., Dev, K., & Joshi, P. C. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100767 · Cited by 10
Role of BMI in the Association of theTCF7L2rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study
Kucharska‐Newton, A., Monda, K. L., Bielinski, S. J., Boerwinkle, E., Rea, T. D., Rosamond, W. D., Pankow, J. S., Köttgen, A., HEISS, G. M., & North, K. E. (2010) · Journal of Obesity · doi:10.1155/2010/651903 · Cited by 10
Variants of transcription factor 7-like 2 (TCF7L2) gene and incident glucose intolerance in Japanese-Brazilians
Franco, L. F., Crispim, F. G. S., Pereira, A. C., & Moisés, R. S. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500010 · Cited by 9
Association between type 2 diabetes mellitus & TCF7L2 gene variants in the Emirati population: Genetics of diabetes in the United Arab Emirates
Khan, S. M., Karte, N. E., Chehadeh, S. E. H., Hassoun, A. A. K., Afandi, B. O., Tay, G. K., & AlSafar, H. S. (2020) · American Journal of Human Biology · doi:10.1002/ajhb.23434 · Cited by 9
Association of transcription factor 7-like 2 rs12255372 polymorphism with susceptibility of type 2 diabetes mellitus in Bangladeshi population
Barman, N., Haque, M. A., Firoz, M., Yusuf, M. A., & Islam, A. B. M. M. K. (2023) · Molecular Genetics and Genomics · doi:10.1007/s00438-023-02049-7 · Cited by 9
R-spondin1 deficiency in mice improves glycaemic control in association with increased beta cell mass
Wong, V. S. C., Oh, A., Chassot, A., Chaboissier, M., & Brubaker, P. L. (2011) · Diabetologia · doi:10.1007/s00125-011-2136-2 · Cited by 9
Genetics of Drug Response in Type 2 Diabetes
Tkáč, I. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0617-2 · Cited by 9
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide
Geng, Z., Li, Q., Huang, R., Wang, J., Weng, J., Zhou, K., Liang, H., & Wang, Y. (2022) · Pharmacogenomics · doi:10.2217/pgs-2021-0154 · Cited by 8
Association of GLP1R Polymorphisms With the Incretin Response
Dorsey-Treviño, E. G., Kaur, V., Mercader, J. M., Florez, J. C., & Leong, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac374 · Cited by 10
Pharmacogenetics of insulin secretagogue antidiabetics
Winkler, G., & Gerő, L. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29175 · Cited by 8
Molecular mechanisms redirecting the GLP-1 receptor signalling profile in pancreatic β-cells during type 2 diabetes
Roussel, M., Mathieu, J., & Dalle, S. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0071 · Cited by 8
Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes
Engelbrechtsen, L., Galijatovic, E. A. A., Roepstorff, S., Hansen, T. F., & Vestergaard, H. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000160 · Cited by 8
Challenges of Implementing Personalized (Precision) Medicine: A Focus on Diabetes
Fodor, A., & Karnieli, E. (2016) · Personalized Medicine · doi:10.2217/pme-2016-0022 · Cited by 8
Gene‐diet quality interactions on haemoglobin A1c and type 2 diabetes risk: The Airwave Health Monitoring Study
Eriksen, R., Gibson, R., Aresu, M., Heard, A., Chan, Q. M., Εvangelou, Ε., Gao, H., Elliott, P., & Frost, G. S. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.74 · Cited by 7
Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
Rodriguez, N. S., & Hartmann, P. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100058 · Cited by 10
Single Nucleotide Polymorphism at rs7903146 of Transcription Factor 7-like 2 gene Among Subjects with Type 2 Diabetes Mellitus in Myanmar
Phu, S., Thida, A., Maung, K. K., & Chit, T. T. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.s2 · Cited by 7
Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation.
Musavi, Z., Azarpira, N., Sangtarash, M. H., Kordi, M., Kazemi, K., Geramizadeh, B., & Malek‐Hosseini, S. A. (2015) · Europe PMC (PubMed Central) · Cited by 7
Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetes.
Preumont, V., Hermans, M. P., Bergman, M., & Buysschaert, M. (2012) · PubMed · doi:10.2143/acb.67.6.2062705 · Cited by 7
Weight loss independent association of TCF7 L2 gene polymorphism with fasting blood glucose after Roux-en-Y gastric bypass in type 2 diabetic patients
Rouskas, K., Cauchi, S., Raverdy, V., Yengo, L., Froguel, P., & Pattou, F. N. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.12.016 · Cited by 7
Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion
Jaghutriz, B. A., Heni, M., Lutz, S. Z., Fritsche, L., Machicao, F. E., Staiger, H., Peter, A., Häring, H., Fritsche, A., & Wagner, R. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00072 · Cited by 7
Self-citation
Role of human Kallistatin in glucose and energy homeostasis in mice
Sandforth, L., Brachs, S., Reinke, J., Willmes, D. M., Sancar, G., Seigner, J., Juarez-Lopez, D., Sandforth, A., McBride, J. D., Ma, J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101905 · Cited by 6
Evaluation of single-nucleotide polymorphisms of transcription factor 7-like 2 and ATP2B1 genes as cardiovascular risk predictors in chronic kidney disease
Sweta, K., Lenin, M., Ramesh, R., Wilma Delphine Silvia, C. R., & Velu, V. K. (2019) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_92_19 · Cited by 6
Genetic Determinants Predicting Efficacy of Glucose-Lowering Drugs?
Nauck, M. A., & Vardarli, I. (2010) · Diabetes Care · doi:10.2337/dc10-1263 · Cited by 6
Carriers of a novel frame-shift insertion in WNT16a possess elevatedpancreatic expression of TCF7L2
Howard, E. W., Been, L. F., Lerner, M. R., Brackett, D. J., Lightfoot, S. A., Bullen, E. C., & Sanghera, D. K. (2013) · BMC Genetics · doi:10.1186/1471-2156-14-28 · Cited by 6
Towards a genotype-based approach for a patient-centered pharmacologic therapy of type 2 diabetes.
Scheen, A. J. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.56 · Cited by 6
TCF7L2 alleles and metabolic syndrome in non-diabetic obese hypertensive patients
Sarzani, R., Salvi, F., Bordicchia, M., Pietrucci, F., Caraceni, D., Lancioni, L., Dessı̀-Fulgheri, P., & RAPPELLI, A. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.8 · Cited by 6
Efficacy of saxagliptin as an add-on to oral monotherapy in the phase 3 clinical development program: Predictive factors of the treatment response in type 2 diabetes
Gautier, J., & Sauvanet, J.-P. (2011) · Annales d Endocrinologie · doi:10.1016/j.ando.2011.05.005 · Cited by 6
Genetic Associations of TCF7L2 (rs7903146) and PPARG (rs1801282) with Prediabetes in the Ethnic Kazakh Population
А.А., Д., Svyatova, G., Berezina, G., Dyussupov, A., Omarkulov, B. K., Dzharmukhametova, A., О.А., Ю., Akhmetova, V., & А.А., Д. (2024) · Diagnostics · doi:10.3390/diagnostics14242769 · Cited by 5
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
Mathiesen, D. S., Bagger, J. I., Hansen, K. B., Junker, A. E., Plamboeck, A., Østoft, S. H., Idorn, T., Hornum, M., Holst, J. J., Jonsson, A. E., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0471 · Cited by 5
Self-citation
Lack of association between single nucleotide polymorphisms in TCF7L2 and T2DM in the Chinese Yao population
Sun, S.-Y., Huang, R.-Z., Huang, H., Zhang, M.-Q., & Sun, H. (2021) · Medicine · doi:10.1097/md.0000000000025326 · Cited by 5
TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population
Potapov, V. A., Шамхалова, М. Ш., Андреевна, С. С., Бельчикова, Л. Н., Суплотова, Л. А., Shestakova, M. V., & Nosikov, V. V. (2010) · Russian Journal of Genetics · doi:10.1134/s1022795410080132 · Cited by 5
Pancreatic Gene Variants Potentially Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes
Jamaluddin, J. L., Huri, H. Z., Vethakkan, S. R., & Mustafa, N. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.234 · Cited by 5
Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population
Kozárová, M., Javorský, M., Stančáková, A., Dobríková, M., Habalová, Klimčáková, L., Židzik, J., Halušková, J., Salagovic, J., & Tkac, I. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657343 · Cited by 5
The association of TCF7L2 rs7903146 polymorphism with type 2 diabetes mellitus among Tatars of Bashkortostan
Avzaletdinova, D. S., Шарипова, Л. Ф., Kochetova, O. V., Моругова, Т. В., Эрдман, В. В., Сомова, Р. Ш., & Mustafina, O. E. (2015) · Diabetes Mellitus · doi:10.14341/dm2004138-45 · Cited by 5
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
Rizvi, A. A., Abbas, M., Verma, S., Verma, S., Khan, A. L., Raza, S. T., & Mahdi, F. (2022) · Global Medical Genetics · doi:10.1055/s-0041-1741109 · Cited by 5
The Contribution of Enteroinsular Hormones to the Pathogenesis of Type 2 Diabetes Mellitus
Diab, D. L., & D’Alessio, D. A. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0114-6 · Cited by 5
ASSOCIATION OF THE POLYMORPHISMS OF THE TCF7L2 GENES WITH TYPE 2 DIABETES
Nikitin, A. G., Potapov, V. A., Бровкин, А. Н., Лаврикова, Е. Ю., Ходырев, Д. С., Shamhalova, M. S., Андреевна, С. С., Суплотова, Л. Н., Shestakova, M. V., Носиков, В. В., et al. (2014) · Journal of clinical practice · doi:10.17816/clinpract514-11 · Cited by 5
Frequency of Transcription Factor 7-like 2 rs12255372 Mutation among Bangladeshi Adult Type 2 Diabetes Patients
Mahmood, S. A., Fariduddin, M., Banu, L. A., Hossain, S. K. S., Masum, M. M., & Selim, S. (2024) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_6_24 · Cited by 4
Diabetes Mellitus
Raffel, L. J., & Goodarzi, M. O. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00090-2 · Cited by 5
GLP 1/2, Enteroglucagon, Glicentin, and Oxyntomodulin
Holst, J. J., Deacon, C. F., & Pedersen, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00168-8 · Cited by 4
Self-citation
Current Knowledge on the Role of Wnt Signaling Pathway in Glucose Homeostasis
Jin, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00029-4 · Cited by 4
Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease
Sharma, A. R., & Vella, A. V. (2016) · Physiology · doi:10.1152/physiol.00009.2016 · Cited by 4
Association of polymorphisms rs290487, rs864745, rs4430796 and rs23136 with type 2 diabetes in the Uyghur population in China.
Deng, X., Liu, H., Nalima, Qiqiger, A., & Zhu, J. (2017) · PubMed Central · Cited by 4
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch12 · Cited by 5
Pharmacogenetics of incretin-based therapies
Yaluri, A. S., Ürgeová, A., Maršálek, M., Javorský, M., & Tkáč, I. (2025) · Postgraduate Medical Journal · doi:10.1093/postmj/qgaf232 · Cited by 3
THE rs7903146 SNP Of TCF7L2 GENE AND ITS ASSOCIATION WITH THE METABOLIC SYNDROME A REVIEW
Rangel, S. R., Araújo, E. M. Q., de Matos, E. M. O., Carvalho, G., & Rios, D. L. S. (2014) · Brazilian Journal of Medicine and Human Health · doi:10.17267/2317-3386bjmhh.v2i3.490 · Cited by 3
Obesity and Diabetes Mellitus
Kamoi, K., & Sasaki, H. (2014) · Internal Medicine Open Access · doi:10.4172/2165-8048.s6-004 · Cited by 3
Rotational night shift work adversely affects expression of TCF7L2 and PPAR-γ genes among healthcare workers with normal glucose tolerance
Madhu, S., Aslam, M., Mishra, B. K., & Mehndiratta, M. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01159-z · Cited by 3
The Genetics of Type 2 Diabetes: From Candidate Gene Biology to Genome‐Wide Studies
Vaxillaire, M., & Froguel, P. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch12 · Cited by 3
Diabetes Susceptibility Polymorphisms and Risk of Prediabetes and Diabetes Complications in the Atherosclerosis Risk in Communities (ARIC) Study
Yan, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kpne-0v56 · Cited by 3
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions
Chastagner, D., Arnion, H., Danthu, C., Touré, F., & Picard, N. (2024) · Pharmacogenomics · doi:10.1080/14622416.2025.2470613 · Cited by 3
Review of the neuroanatomic landscape implicated in glucose sensing and regulation of nutrient signaling: Immunophenotypic localization of diabetes gene Tcf7l2 in the developing murine brain
Weaver, C. V., Turner, N., & Hall, J. L. (2012) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.06.002 · Cited by 2
Patient profiling in diabetes and role of canagliflozin
Amblee, A. P. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s52761 · Cited by 2
Common variants of transcription factor 7-like 2 (TCF7L2) are associated with reduced insulin secretion in women with polycystic ovary syndrome
Liu, B., Lv, H., Li, L.-N., Xia, L., Zhang, H., Zhang, Y., & Lei, L. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650755 · Cited by 2
Diabetes
Udler, M. S., & Florez, J. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800685-6.00014-x · Cited by 2
Genotype and Tissue-Specific Effects on Alternative Splicing of the Transcription Factor 7-Like 2 Gene in Humans
Mondal, A. K., Das, S. K., Baldini, G., Chu, W. S., Sharma, N., Hackney, O. G., Zhao, J., Grant, S. F. A., & Elbein, S. C. (2010) · Molecular Endocrinology · doi:10.1210/mend.24.2.9994 · Cited by 2
Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review
Golovina, E. L., Романович, Г. И., Ваизова, О. Е., Самойлова, Ю. Г., Подчиненова, Д. В., Матвеева, М. В., & Kudlay, D. A. (2023) · Terapevticheskii arkhiv · doi:10.26442/00403660.2023.03.202150 · Cited by 2
Assessment of TCF7L2 expression after bariatric surgery
Macedo, C. E. S., da Conti, G., Catena, A. D. S., Bruneska, D., Rosa, M., Noronha, C. G., Santa‐Cruz, F., & Ferraz, Á. A. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216627 · Cited by 2
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch16 · Cited by 2
High-Fat Diet-Fed Kcnq1 Mutant Mice Have Reduced Pancreatic β-Cell Mass via Gene-Environment Interaction
Asahara, S., Inoue, H., Ihara, Y., Teruyama, K., Imai, A., Hara, C., Hara, M., Seike, M., Yokoi, A., Kido, N., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0790 · Cited by 1
Multidimensional Predictors of Tirzepatide Efficacy: Clinical, Genetic, and Molecular Biomarkers for Glycemic, Weight, and Organ Protection
Shin, M. H., Jeong, J. W., Ha, S. E., Singh, R., Lee, M. Y., Ro, S., & Yu, T. Y. (2026) · Pharmaceuticals · doi:10.3390/ph19050791 · Cited by 1
Diabetes
Florez, J. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00082-3 · Cited by 1
Common Genetic Variation Influences the Heterogeneity of Response to Oral Glucose
Vella, A. V. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0119-1 · Cited by 1
Prevention of Diabetes and 4P Medicine
Moța, M. (2017) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2017-0001 · Cited by 2
Research Article Association of TCF7L2 rs12255372 –G/T polymorphism with type 2 diabetes in a Nigerian population
Engwa, G. A., Nwalo, F. N., Ozokonkwo, C. O., Agbafor, K. N., Nkeh-Chungag, B. N., & Ubi, B. E. (2021) · Genetics and Molecular Research · doi:10.4238/gmr18662 · Cited by 1
Wnt Signaling in Pancreatic Islets
Habener, J. F., & Liu, Z. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_13-2 · Cited by 1
Genetik des Typ-2-Diabetes
Wagner, R. J., & Staiger, H. (2019) · Der Diabetologe · doi:10.1007/s11428-019-0474-8 · Cited by 1
Secreted Frizzled-Related Proteins 4 and 5: What They Are and Can They Be Used as a Biomarker in Gestational Diabetes Mellitus
Beernink, R. H. J., & Schuitemaker, J. H. N. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_33 · Cited by 1
The association of DNA methylation patterns in TCF7L2 and GIPR genes with Type 2 Diabetes
Canivell, S. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
The grey zone between type 1 and type 2 diabetes : genetic aspects of diabetes in adults
Andersen, M. K. (2012) · Työväentutkimus Vuosikirja · Cited by 1
The molecular and genetic basis of type 2 diabetes mellitus
Wei, N., & Florez, J. C. (2009) · Dialnet (Universidad de la Rioja) · Cited by 1
Transcription Factor 7-like 2 (TCF7L2) Gene Polymorphisms in Relation to the Risk of Type 2 Diabetes in three ethnicities
Xu, L. (2018) · doi:10.25148/etd.fidc006818 · Cited by 1
Genetic studies of diabetes in northern Sweden
Mayans, S. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Gene x lifestyle interactions in type 2 diabetes mellitus and related traits
Brito, E. C. (2010) · DiVA at Umeå University (Umeå University)
Polimorfizm rs7903146 genu TCF7L2 a występowanie nadwagi i otyłości u osób zgłaszających się do poradni ogólnej podstawowej opieki zdrowotnej
Kała, E., Bodek, I., Trelińska, O., Gładysz, P., Lepiarczyk, O., Śmigel, A., Gola, M., & Grzeszczak, W. (2014) · Annales Academiae Medicae Silesiensis
Análise da resposta hormonal pancreática antes e após tratamento com GLP-1 mimético em indivíduos com diabetes tipo 2 portadores da variante rs7903146 do gene TCF7L2
Ferreira, M. C. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2013.tde-01112013-113904
Associação entre TCF7L2 e outras variantes genéticas de risco para Diabetes Mellitus Tipo 2 e doença cardiovascular
de Sousa, A. G. P. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-18022011-161431
Untersuchung der Effekte des GLP-1 Systems auf Komponenten des Metabolischen Syndrom in vivo
Piotrowski, K. (2013) · doi:10.5282/edoc.15458
Mechanisms by which variants in the TCF7L2 gene increase the risk of developing Type 2 diabetes
Zhou, Y. (2013) · Lund University Publications (Lund University)
Génétique du diabète de type 2: comment évaluer l’héritabilité de la capacité sécrétoire de la cellule β ?
Franc, S. (2010) · Diabetologia Notes de lecture · doi:10.1007/s13116-010-0039-x
Association gliptines et sulfamides hypoglycémiants
Dejager, S., & Grimaldi, A. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)74929-0
Molecular regulation of hormone secretion, growth and apoptosis of GLP-1-producing cells
Kappe, C. (2012) · Figshare
Incrétines, incrétinomimétiques et inhibiteurs de la DPP-4 : homéostasie glucidique et diabète de type 2
Virally, M., Kévorkian, J.-P., & Guillausseau, P.-J. (2008) · Sang thrombose vaisseaux · doi:10.1684/stv.2008.0329
Diabetes in China 2 Causes of type 2 diabetes in China
Ching, R., Wan, M., Xu, L., & Jia, W. (2014)
Marine invertebrate and bacterial extract library screens for novel modulators of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell
Lim, G. E. (2010) · TSpace (University of Toronto)
Genetic Variants and Risk of Diabetes
Lyssenko, V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00020-8
Crosstalk between Insulin and Wnt Signaling Pathways
Sun, J. (2010) · TSpace (University of Toronto)
Progressive Impairment in Glucose Homeostasis 2
Ip, W., Shao, W., Song, Z., Chen, Z., & Wheeler, M. B. (2015)
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
The Role of Transcription Factor 7-Like 2 in Hepatic Glucose Metabolism
Ip, W. (2014) · TSpace (University of Toronto)
A MODEL OF BETA-CELL RESPONSE TO GLP-1 TO QUANTIFY INCRETIN EFFECT IN HEALTHY AND PREDIABETIC SUBJECTS
Micheletto, F. (2013) · Padua@research (University of Padova)

Authors: Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., & Fritsche, A.
Affiliations: University of Tübingen (DE)
University of Copenhagen (DK)
Amsterdam Public Health (NL)
Corresponding author: Fritsche, A.
ORCID: Stefan, N.
Gallwitz, B.
Holst, J. J.
Nijpels, G.
Fritsche, A.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2007-07-28
Volume: 50
Issue: 12
Pages: 2443-2450
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-007-0753-6
PMC: PMC2063563
OpenAlex: W2132717133
Cited by: 308
References: 30
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 18 · 2018: 14 · 2017: 10 · 2016: 15 · 2015: 15 · 2014: 26 · 2013: 17 · 2012: 23
FWCI: 32.85
Type: journal article
Language: en
Update notices: correction (2007-11-10)
correction (2009-01-08)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
VU Research Portal (publishedVersion, other-oa)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders: Deutsche Forschungsgemeinschaft (KFO 114)
ZonMw
Centre for Medical Systems Biology
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: TCF7L2, glucagon-like peptide-1, insulin secretion, type 2 diabetes risk, single nucleotide polymorphisms, enteroinsular axis, GLP-1 secretion, GLP-1 receptor, rs7903146, rs12255372, risk alleles
MeSH terms: Insulin Secretion, Adult, Arginine, Blood Glucose, Female, Glucose Tolerance Test, Heterozygote, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Glucose Clamp Technique, Glucose Intolerance, Polymorphism, Single Nucleotide, TCF Transcription Factors, Glucagon-Like Peptide 1, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks